Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Atlas Arteria ( (AU:ALX) ) is now available.
Atlas Arteria has released its financial results for the half-year ending June 30, 2025, in compliance with Australian Accounting Standards. The report, which aligns with IFRS standards, is intended to be read alongside the company’s annual financial report for 2024. This release may impact stakeholders by providing insights into the company’s financial health and operational performance, potentially affecting its market positioning and investor confidence.
The most recent analyst rating on (AU:ALX) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a company that partners to deliver world-class road experiences through toll road businesses. It operates in France, Germany, and the United States, with significant interests in motorway networks and toll roads such as the APRR in France, the Chicago Skyway, and the Dulles Greenway in the US, and the Warnow Tunnel in Germany. The company focuses on creating long-term value for stakeholders through disciplined management and sustainable business practices.
Average Trading Volume: 2,012,556
Technical Sentiment Signal: Buy
Current Market Cap: A$7.82B
For detailed information about ALX stock, go to TipRanks’ Stock Analysis page.